nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—GRIA2—amyotrophic lateral sclerosis	0.851	1	CbGaD
Methylphenobarbital—CHRNA4—peripheral nervous system—amyotrophic lateral sclerosis	0.004	0.0542	CbGeAlD
Methylphenobarbital—GRIK2—nerve—amyotrophic lateral sclerosis	0.00388	0.0526	CbGeAlD
Methylphenobarbital—GRIA2—hindbrain—amyotrophic lateral sclerosis	0.00322	0.0436	CbGeAlD
Methylphenobarbital—CHRNA4—nerve—amyotrophic lateral sclerosis	0.00312	0.0423	CbGeAlD
Methylphenobarbital—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00311	0.0421	CbGeAlD
Methylphenobarbital—GRIK2—hindbrain—amyotrophic lateral sclerosis	0.00291	0.0394	CbGeAlD
Methylphenobarbital—Hexobarbital—GRIA2—amyotrophic lateral sclerosis	0.00269	0.483	CrCbGaD
Methylphenobarbital—CHRNA4—hindbrain—amyotrophic lateral sclerosis	0.00234	0.0317	CbGeAlD
Methylphenobarbital—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00209	0.0283	CbGeAlD
Methylphenobarbital—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00202	0.0274	CbGeAlD
Methylphenobarbital—GRIA2—embryo—amyotrophic lateral sclerosis	0.00201	0.0273	CbGeAlD
Methylphenobarbital—GRIA2—brainstem—amyotrophic lateral sclerosis	0.00184	0.025	CbGeAlD
Methylphenobarbital—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00178	0.0242	CbGeAlD
Methylphenobarbital—GRIK2—brainstem—amyotrophic lateral sclerosis	0.00167	0.0226	CbGeAlD
Methylphenobarbital—Primidone—GRIA2—amyotrophic lateral sclerosis	0.00156	0.28	CrCbGaD
Methylphenobarbital—CHRNA4—brainstem—amyotrophic lateral sclerosis	0.00134	0.0182	CbGeAlD
Methylphenobarbital—GABRA2—brainstem—amyotrophic lateral sclerosis	0.0012	0.0162	CbGeAlD
Methylphenobarbital—GRIK2—medulla oblongata—amyotrophic lateral sclerosis	0.00116	0.0157	CbGeAlD
Methylphenobarbital—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00116	0.0157	CbGeAlD
Methylphenobarbital—GRIA2—spinal cord—amyotrophic lateral sclerosis	0.00115	0.0155	CbGeAlD
Methylphenobarbital—GRIK2—spinal cord—amyotrophic lateral sclerosis	0.00104	0.014	CbGeAlD
Methylphenobarbital—Phenobarbital—GRIA2—amyotrophic lateral sclerosis	0.000983	0.177	CrCbGaD
Methylphenobarbital—GRIA2—nervous system—amyotrophic lateral sclerosis	0.000966	0.0131	CbGeAlD
Methylphenobarbital—GABRA6—nervous system—amyotrophic lateral sclerosis	0.000933	0.0127	CbGeAlD
Methylphenobarbital—GRIA2—central nervous system—amyotrophic lateral sclerosis	0.00093	0.0126	CbGeAlD
Methylphenobarbital—GRIA2—cerebellum—amyotrophic lateral sclerosis	0.000909	0.0123	CbGeAlD
Methylphenobarbital—GABRA5—nervous system—amyotrophic lateral sclerosis	0.000905	0.0123	CbGeAlD
Methylphenobarbital—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.000898	0.0122	CbGeAlD
Methylphenobarbital—CHRFAM7A—nervous system—amyotrophic lateral sclerosis	0.00088	0.0119	CbGeAlD
Methylphenobarbital—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.000878	0.0119	CbGeAlD
Methylphenobarbital—GRIK2—nervous system—amyotrophic lateral sclerosis	0.000873	0.0118	CbGeAlD
Methylphenobarbital—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.000872	0.0118	CbGeAlD
Methylphenobarbital—CHRFAM7A—central nervous system—amyotrophic lateral sclerosis	0.000847	0.0115	CbGeAlD
Methylphenobarbital—GABRA3—nervous system—amyotrophic lateral sclerosis	0.000843	0.0114	CbGeAlD
Methylphenobarbital—GRIK2—central nervous system—amyotrophic lateral sclerosis	0.00084	0.0114	CbGeAlD
Methylphenobarbital—CHRNA4—spinal cord—amyotrophic lateral sclerosis	0.000832	0.0113	CbGeAlD
Methylphenobarbital—GABRA4—nervous system—amyotrophic lateral sclerosis	0.000821	0.0111	CbGeAlD
Methylphenobarbital—GRIK2—cerebellum—amyotrophic lateral sclerosis	0.000821	0.0111	CbGeAlD
Methylphenobarbital—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.000811	0.011	CbGeAlD
Methylphenobarbital—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.000807	0.0109	CbGeAlD
Methylphenobarbital—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.000791	0.0107	CbGeAlD
Methylphenobarbital—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.000773	0.0105	CbGeAlD
Methylphenobarbital—GRIA2—brain—amyotrophic lateral sclerosis	0.000738	0.01	CbGeAlD
Methylphenobarbital—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00072	0.00976	CbGeAlD
Methylphenobarbital—GABRA6—brain—amyotrophic lateral sclerosis	0.000713	0.00967	CbGeAlD
Methylphenobarbital—CHRNA7—nervous system—amyotrophic lateral sclerosis	0.000711	0.00964	CbGeAlD
Methylphenobarbital—CHRNA4—nervous system—amyotrophic lateral sclerosis	0.000701	0.00951	CbGeAlD
Methylphenobarbital—GABRA5—brain—amyotrophic lateral sclerosis	0.000692	0.00938	CbGeAlD
Methylphenobarbital—CHRNA7—central nervous system—amyotrophic lateral sclerosis	0.000684	0.00928	CbGeAlD
Methylphenobarbital—CHRNA4—central nervous system—amyotrophic lateral sclerosis	0.000675	0.00916	CbGeAlD
Methylphenobarbital—CHRFAM7A—brain—amyotrophic lateral sclerosis	0.000673	0.00912	CbGeAlD
Methylphenobarbital—GRIK2—brain—amyotrophic lateral sclerosis	0.000667	0.00905	CbGeAlD
Methylphenobarbital—CHRNA4—cerebellum—amyotrophic lateral sclerosis	0.00066	0.00895	CbGeAlD
Methylphenobarbital—GABRA3—brain—amyotrophic lateral sclerosis	0.000644	0.00874	CbGeAlD
Methylphenobarbital—GABRA4—brain—amyotrophic lateral sclerosis	0.000628	0.00851	CbGeAlD
Methylphenobarbital—GABRA2—nervous system—amyotrophic lateral sclerosis	0.000628	0.00851	CbGeAlD
Methylphenobarbital—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000607	0.00823	CbGeAlD
Methylphenobarbital—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.000604	0.0082	CbGeAlD
Methylphenobarbital—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.000591	0.00801	CbGeAlD
Methylphenobarbital—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000584	0.00792	CbGeAlD
Methylphenobarbital—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000571	0.00774	CbGeAlD
Methylphenobarbital—CHRNA7—brain—amyotrophic lateral sclerosis	0.000543	0.00737	CbGeAlD
Methylphenobarbital—CHRNA4—brain—amyotrophic lateral sclerosis	0.000536	0.00727	CbGeAlD
Methylphenobarbital—GABRA2—brain—amyotrophic lateral sclerosis	0.00048	0.00651	CbGeAlD
Methylphenobarbital—GABRA1—brain—amyotrophic lateral sclerosis	0.000464	0.00629	CbGeAlD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000409	0.00585	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000409	0.00585	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000408	0.00584	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000406	0.00581	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000403	0.00577	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000396	0.00567	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000394	0.00564	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000391	0.0056	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.00038	0.00543	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000375	0.00536	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000373	0.00533	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000372	0.00532	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000369	0.00527	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000369	0.00527	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000366	0.00523	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000361	0.00516	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000361	0.00516	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000361	0.00516	CbGpPWpGaD
Methylphenobarbital—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000358	0.00485	CbGeAlD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000354	0.00507	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000348	0.00498	CbGpPWpGaD
Methylphenobarbital—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000344	0.00467	CbGeAlD
Methylphenobarbital—GRIK2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000344	0.00492	CbGpPWpGaD
Methylphenobarbital—Antipyrine—PTGS2—amyotrophic lateral sclerosis	0.000341	0.0611	CrCbGaD
Methylphenobarbital—CHRNA7—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000339	0.00485	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000335	0.0048	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000335	0.0048	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000335	0.0048	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000333	0.00477	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000333	0.00477	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000333	0.00477	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000333	0.00477	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000333	0.00476	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000332	0.00475	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000331	0.00474	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000331	0.00474	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000328	0.0047	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000327	0.00468	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000321	0.0046	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000321	0.0046	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00032	0.00458	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.000319	0.00456	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000313	0.00448	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000309	0.00443	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000305	0.00437	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000304	0.00435	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000303	0.00434	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000302	0.00432	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000299	0.00428	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000297	0.00425	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000294	0.00421	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000294	0.00421	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000289	0.00413	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000285	0.00408	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000285	0.00408	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000284	0.00406	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000282	0.00404	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000282	0.00404	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000282	0.00403	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000282	0.00403	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000282	0.00403	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000276	0.00395	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000276	0.00395	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000276	0.00394	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000274	0.00392	CbGpPWpGaD
Methylphenobarbital—CYP2B6—brain—amyotrophic lateral sclerosis	0.000273	0.00371	CbGeAlD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000273	0.00391	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000273	0.00391	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000272	0.00389	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000271	0.00388	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000266	0.00381	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000262	0.00375	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000257	0.00368	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000257	0.00368	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000255	0.00365	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000254	0.00363	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000252	0.00361	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000252	0.0036	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000252	0.0036	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000251	0.00359	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00025	0.00358	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000249	0.00356	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000246	0.00352	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000246	0.00352	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000244	0.00349	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000242	0.00346	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000242	0.00346	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000242	0.00346	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000237	0.0034	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000237	0.00339	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000234	0.00335	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000234	0.00335	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000234	0.00335	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000233	0.00334	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000232	0.00332	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000231	0.00331	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000231	0.00331	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.00328	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000225	0.00322	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000223	0.00319	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000221	0.00316	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000219	0.00313	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000217	0.00311	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000216	0.00309	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000216	0.00309	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000216	0.00309	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000213	0.00305	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000212	0.00303	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000211	0.00302	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000209	0.003	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000209	0.003	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000209	0.00299	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000209	0.00298	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000208	0.00297	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000206	0.00295	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000206	0.00295	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000206	0.00295	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000206	0.00295	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000206	0.00295	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000206	0.00294	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000206	0.00294	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000204	0.00292	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000202	0.00289	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000202	0.00289	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000201	0.00287	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000199	0.00285	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000198	0.00284	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000198	0.00284	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000193	0.00276	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000192	0.00275	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000192	0.00275	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000191	0.00273	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00019	0.00271	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000188	0.0027	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000187	0.00267	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000185	0.00265	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000185	0.00265	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000183	0.00262	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000182	0.0026	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000182	0.0026	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00018	0.00258	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00018	0.00257	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00018	0.00257	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000179	0.00256	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000177	0.00254	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000177	0.00254	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000177	0.00253	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000176	0.00252	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000174	0.00249	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000173	0.00247	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000171	0.00245	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000169	0.00242	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000169	0.00242	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000169	0.00242	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000166	0.00238	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000166	0.00237	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000164	0.00234	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00016	0.00229	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000158	0.00226	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000158	0.00226	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000158	0.00225	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000158	0.00225	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000156	0.00223	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000155	0.00221	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000155	0.00221	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000155	0.00221	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000152	0.00218	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000152	0.00218	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000152	0.00218	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000152	0.00217	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000151	0.00216	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000149	0.00213	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00014	0.00201	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000139	0.002	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000138	0.00197	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000136	0.00194	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00013	0.00186	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00013	0.00186	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00013	0.00186	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000127	0.00182	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000118	0.00169	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000116	0.00165	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000114	0.00162	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000112	0.0016	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000107	0.00153	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000106	0.00151	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.96e-05	0.00143	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.78e-05	0.0014	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.66e-05	0.00138	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.66e-05	0.00138	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	9.62e-05	0.00138	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.53e-05	0.00136	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.53e-05	0.00136	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	9.47e-05	0.00136	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.07e-05	0.0013	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	8.97e-05	0.00128	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.62e-05	0.00123	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.61e-05	0.00123	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.5e-05	0.00122	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.47e-05	0.00121	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.47e-05	0.00121	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.32e-05	0.00119	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.32e-05	0.00119	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.3e-05	0.00119	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.2e-05	0.00117	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	8.18e-05	0.00117	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	8.18e-05	0.00117	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.71e-05	0.0011	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.55e-05	0.00108	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.41e-05	0.00106	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.34e-05	0.00105	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.31e-05	0.00105	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	7.29e-05	0.00104	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.25e-05	0.00104	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.98e-05	0.000998	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.97e-05	0.000997	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.97e-05	0.000997	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.88e-05	0.000985	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.21e-05	0.000889	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	5.35e-05	0.000765	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	5.35e-05	0.000765	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	5.34e-05	0.000763	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.27e-05	0.000754	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.2e-05	0.000744	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.97e-05	0.000711	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.89e-05	0.0007	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.55e-05	0.000651	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.53e-05	0.000648	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.27e-05	0.000612	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	4.04e-05	0.000578	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	4.04e-05	0.000578	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.87e-05	0.000553	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.77e-05	0.000539	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	3.7e-05	0.000529	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.44e-05	0.000492	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	3.23e-05	0.000462	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.93e-05	0.000419	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.92e-05	0.000418	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.7e-05	0.000387	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000318	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.21e-05	0.000317	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.04e-05	0.000292	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000266	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.68e-05	0.00024	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.53e-05	0.000219	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.19e-05	0.000171	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	0.000157	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.05e-05	0.00015	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	9.02e-06	0.000129	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.02e-06	0.000129	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.29e-06	0.000119	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	6.82e-06	9.76e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.18e-06	8.85e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.67e-06	6.68e-05	CbGpPWpGaD
